Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2024 08:00 ET | Source: Recursion Pharmaceuticals

Recursion Publishes Annual Environmental, Social and Governance Report

SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
March 01, 2024 14:58 ET | Source: Recursion Pharmaceuticals

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community

SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, hosted its second annual Rare...
March 01, 2024 07:59 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
February 27, 2024 16:05 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Multiple clinical programs from Recursion’s first generation platform are on track to read out Phase 2 data in H2 2024 and H1 2025 with additional second generation programs approaching IND in the...
February 20, 2024 07:59 ET | Source: Recursion Pharmaceuticals

Recursion to Host Public L(earnings) Call on February 27

SALT LAKE CITY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
January 24, 2024 09:00 ET | Source: Recursion Pharmaceuticals

Altitude Lab Startups Raise Over $120M in Capital

SALT LAKE CITY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altitude Lab today announced that its incubating startups raised over $120M in early-stage funding since commencing operations in 2020. Altitude Lab...
January 08, 2024 10:59 ET | Source: Recursion Pharmaceuticals

Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...
January 03, 2024 08:00 ET | Source: Recursion Pharmaceuticals

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

SALT LAKE CITY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Chris...
December 20, 2023 07:59 ET | Source: Recursion Pharmaceuticals

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today...
November 09, 2023 09:41 ET | Source: Recursion Pharmaceuticals

Bayer and Recursion Focus Research Collaboration on Oncology

Berlin, Germany and Salt Lake City, USA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug...